Rigel Pharmaceuticals (RIGL) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Rigel Pharmaceuticals (RIGL) over the last 17 years, with Q3 2025 value amounting to -$137.1 million.
- Rigel Pharmaceuticals' Enterprise Value fell 12440.52% to -$137.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$137.1 million, marking a year-over-year decrease of 12440.52%. This contributed to the annual value of -$77.3 million for FY2024, which is 3581.05% down from last year.
- As of Q3 2025, Rigel Pharmaceuticals' Enterprise Value stood at -$137.1 million, which was down 12440.52% from -$108.4 million recorded in Q2 2025.
- In the past 5 years, Rigel Pharmaceuticals' Enterprise Value registered a high of -$39.3 million during Q1 2021, and its lowest value of -$153.4 million during Q2 2021.
- In the last 5 years, Rigel Pharmaceuticals' Enterprise Value had a median value of -$77.1 million in 2025 and averaged -$84.2 million.
- As far as peak fluctuations go, Rigel Pharmaceuticals' Enterprise Value surged by 5898.4% in 2021, and later tumbled by 17327.23% in 2022.
- Over the past 5 years, Rigel Pharmaceuticals' Enterprise Value (Quarter) stood at -$125.0 million in 2021, then skyrocketed by 53.42% to -$58.2 million in 2022, then increased by 2.19% to -$56.9 million in 2023, then crashed by 35.81% to -$77.3 million in 2024, then tumbled by 77.37% to -$137.1 million in 2025.
- Its last three reported values are -$137.1 million in Q3 2025, -$108.4 million for Q2 2025, and -$77.1 million during Q1 2025.